entertainment -WSS

entertainment

author：focus 2025-08-11 09:49:44 - browse：95

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Living with Hashimoto's and celiac disease, and med school, too

explore

WSS

Hundreds died while taking an arthritis drug, but nobody alerted patients

Covid silver lining: Unprecedented look at human immune system

Hilary expected to bring catastrophic, life

Gut bacteria may contribute to kidney autoimmunity, study finds

Hilary expected to bring catastrophic, life

As Maui death toll rises, number of missing remains unclear

hotspot

entertainment

focus

Supreme Court strikes down use of affirmative action

Scientific mystery highlights the blind spots in genomics databases

Affirmative action in medical school literally saved lives

Trial using CRISPR to edit HIV out of cells disappoints

Psychedelics group wrestles with new pharma identity

The pain doctors face in trying to build their families

Tori Bowie and the unacceptable rates of Black maternal death

As Maui death toll rises, number of missing remains unclear

Drug repurposing or repositioning? The language matters

Mass General Brigham physicians react to latest merger step

focus

First Opinion on colorectal cancer screening: letter and response

Scientific mystery highlights the blind spots in genomics databases

Republican states more likely to report Covid vaccine side effects

Young boy dies in trial for Pfizer Duchenne gene therapy

Clinical trials must include more disabled people

Pancreatic cancer is often deadly, but new discoveries are raising hope

knowledge

leisure time

explore

knowledge